Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression.

Rabenda V, Bruyère O, Reginster JY.

Osteoporos Int. 2011 Mar;22(3):893-901. doi: 10.1007/s00198-010-1469-x.

PMID:
21060990
2.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

3.

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women.

Bruyere O, Varela AR, Adami S, Detilleux J, Rabenda V, Hiligsmann M, Reginster JY.

Eur J Epidemiol. 2009;24(11):707-12. doi: 10.1007/s10654-009-9381-4. Epub 2009 Aug 29.

PMID:
19728118
4.

Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12-month randomized controlled study.

Flodin L, Sääf M, Cederholm T, Al-Ani AN, Ackermann PW, Samnegård E, Dalen N, Hedström M.

Clin Interv Aging. 2014 Jul 7;9:1043-50. doi: 10.2147/CIA.S63987. eCollection 2014.

5.

Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.

Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.

Epilepsia. 2013 Nov;54(11):1997-2004. doi: 10.1111/epi.12351. Epub 2013 Sep 6.

6.

The impact of dietary calcium intake and vitamin D status on the effects of zoledronate.

Bourke S, Bolland MJ, Grey A, Horne AM, Wattie DJ, Wong S, Gamble GD, Reid IR.

Osteoporos Int. 2013 Jan;24(1):349-54. doi: 10.1007/s00198-012-2117-4. Epub 2012 Aug 15.

PMID:
22893357
7.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

8.

Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.

Sakai A, Ito M, Tomomitsu T, Tsurukami H, Ikeda S, Fukuda F, Mizunuma H, Inoue T, Saito H, Nakamura T; e-ADVANCED Study Group.

Osteoporos Int. 2015 Mar;26(3):1193-202. doi: 10.1007/s00198-014-2991-z. Epub 2015 Jan 16. Erratum in: Osteoporos Int. 2015 Apr;26(4):1453.

9.

Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study.

Nieves JW, Barrett-Connor E, Siris ES, Zion M, Barlas S, Chen YT.

Osteoporos Int. 2008 May;19(5):673-9. Epub 2007 Nov 13.

PMID:
17999024
10.
11.

Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis.

Winzenberg T, Powell S, Shaw KA, Jones G.

BMJ. 2011 Jan 25;342:c7254. doi: 10.1136/bmj.c7254. Review.

12.

The Effect of Calcium or Calcium and Vitamin D Supplementation on Bone Mineral Density in Healthy Males: A Systematic Review and Meta-Analysis.

Silk LN, Greene DA, Baker MK.

Int J Sport Nutr Exerc Metab. 2015 Oct;25(5):510-24. doi: 10.1123/ijsnem.2014-0202. Epub 2015 Feb 12. Review.

PMID:
25675442
13.

Accelerated bone mineral loss following a hip fracture: a prospective longitudinal study.

Dirschl DR, Henderson RC, Oakley WC.

Bone. 1997 Jul;21(1):79-82.

PMID:
9213011
14.

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D.

Alibhai SM, Mohamedali HZ, Gulamhusein H, Panju AH, Breunis H, Timilshina N, Fleshner N, Krahn MD, Naglie G, Tannock IF, Tomlinson G, Warde P, Duff Canning S, Cheung AM.

Osteoporos Int. 2013 Oct;24(10):2571-9. doi: 10.1007/s00198-013-2343-4. Epub 2013 Apr 6.

PMID:
23563932
15.

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.

Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY.

Calcif Tissue Int. 2005 Mar;76(3):176-86. Epub 2005 Feb 7.

PMID:
15692726
16.
17.

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.

Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY.

J Clin Endocrinol Metab. 2007 Aug;92(8):3076-81. Epub 2007 Jun 12.

18.

Vitamin D supplementation for improving bone mineral density in children.

Winzenberg TM, Powell S, Shaw KA, Jones G.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006944. doi: 10.1002/14651858.CD006944.pub2. Review.

PMID:
20927753
19.

Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.

Angthong C, Rodjanawijitkul S, Samart S, Angthong W.

Acta Orthop Traumatol Turc. 2013;47(5):318-22.

20.

Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation.

Shams-White MM, Chung M, Du M, Fu Z, Insogna KL, Karlsen MC, LeBoff MS, Shapses SA, Sackey J, Wallace TC, Weaver CM.

Am J Clin Nutr. 2017 Jun;105(6):1528-1543. doi: 10.3945/ajcn.116.145110. Epub 2017 Apr 12. Review.

PMID:
28404575

Supplemental Content

Support Center